Recent developments in our understanding of sepsis: Evaluation of anti-endotoxin antibodies and biological response modifiers
- 31 December 1993
- journal article
- review article
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 22 (12) , 1871-1890
- https://doi.org/10.1016/s0196-0644(05)80417-2
Abstract
No abstract availableKeywords
This publication has 115 references indexed in Scilit:
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992
- Strategies for diagnosis and treatment of children at risk for occult bacteremia: Clinical effectiveness and cost-effectivenessThe Journal of Pediatrics, 1991
- Management of infants at risk for occult bacteremia: A decision analysisThe Journal of Pediatrics, 1991
- Activation of Coagulation after Administration of Tumor Necrosis Factor to Normal SubjectsNew England Journal of Medicine, 1990
- Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious PurpuraNew England Journal of Medicine, 1988
- Effect of High-Dose Glucocorticoid Therapy on Mortality in Patients with Clinical Signs of Systemic SepsisNew England Journal of Medicine, 1987
- A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 1987
- A comparative study of the prevalence, outcome, and prediction of bacteremia in childrenThe Journal of Pediatrics, 1983
- Febrile infants: Predictors of bacteremiaThe Journal of Pediatrics, 1982
- Bacteremia in febrile children under 2 years of age: Results of cultures of blood of 600 consecutive febrile children seen in a “walk-in” clinicThe Journal of Pediatrics, 1975